EFFECTS OF ATORVASTATIN ON BLOOD PRESSURE AND URINARY ALBUMIN EXCRETION IN PATIENTS WITH ESSENTIAL HYPERTENSION.

Trial Profile

EFFECTS OF ATORVASTATIN ON BLOOD PRESSURE AND URINARY ALBUMIN EXCRETION IN PATIENTS WITH ESSENTIAL HYPERTENSION.

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Feb 2013

At a glance

  • Drugs Atorvastatin (Primary)
  • Indications Essential hypertension; Hypercholesterolaemia
  • Focus Pharmacodynamics
  • Acronyms STAY
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 01 Sep 2011 Results published in the Journal of Human Hypertension.
    • 20 Jun 2011 Results assessing the effect of treatment on ambulatory blood pressure presented at the 21st European Meeting on Hypertension.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top